A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7)

Clinical trial NCT02432144 · COMPLETED

Trial details

NCT number: NCT02432144
Sponsor: Ultragenyx Pharmaceutical Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sly Syndrome MPS VII Mucopolysaccharidosis Mucopolysaccharidosis VII

Start date: 2015-11-10
Primary completion: 2019-01-14
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.